Biography and Research Information
OverviewAI-generated summary
Denese Harris's research has focused on hematologic conditions and stem cell transplantation. Her work includes a 2025 publication examining hyperhemolysis in sickle cell disease, drawing insights from existing literature. Additionally, she co-authored a 2021 study on improved clinical outcomes with busulfan-based conditioning in allogeneic stem cell transplantation, specifically utilizing peripheral blood T-cell replete procedures with post-transplant cyclophosphamide for graft-versus-host disease prophylaxis. This study was a single-center experience. Harris has a publication count of two and has received four citations, with an h-index of 1. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Ankur Varma, Medhavi Honhar, Mamatha Gaddam, and Sunny Singh, with whom she has co-authored one publication each.
Metrics
- h-index: 1
- Publications: 2
- Citations: 6
Selected Publications
-
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025)
Collaboration Network
Top Collaborators
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Improved Clinical Outcome with Busulfan Based Conditioning Using Peripheral Blood T Cell Replete Allogenic Stem Cell Transplantation (alloSCT) with Post Transplant Cyclophosphamide (PTCy) Based GVHD Prophylaxis: A Single Center Experience
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
Similar Researchers
Based on overlapping research topics